DRUG

#2303
Bright Minds Biosciences Inc. - common stock
88.0 7 USD
-1.82%
Сектор: Здравоохранение
Базовая: USD
Валюта прибыли: USD
Дневной диапазон
88.07
88.07
Годовой диапазон
23.18
123.75
Дневное изменение
-1.82%
Месячное изменение
-1.01%
6-месячное изменение
+26.27%
Годовое изменение
+224.98%
Предыдущее закрытие
89.7 0
Open
88.0 7
Low
88.0 7
High
88.0 7
Volume
24
Открыть полный график Full chart

Financials

Обзор Отчетность Статистика
Квартал Год
Отчет о доходах Баланс Денежный поток
Значение 20212022202320242025 TTM

Bright Minds Biosciences Inc. - common stock

Bright Minds Biosciences is an American pharmaceutical company which is developing serotonin 5-HT₂ receptor agonists for potential medical use. It has a particular focus on serotonin 5-HT2C receptor agonists, for instance to treat rare epilepsies and other conditions. Another area of focus for the company is serotonergic psychedelics and non-hallucinogenic psychoplastogens. The company was co-founded by Ian McDonald and Gideon Shapiro. The lead scientist at Bright Minds Biosciences was previously Alan Kozikowski. Bright Mind Biosciences was founded in 2017 and its headquarters are in New York City, New York.

Новости